Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells.

The mammalian securin, pituitary tumor-transforming gene (PTTG), is overexpressed in several tumors and transforms cells in vitro and in vivo. To test the hypothesis that PTTG overexpression causes aneuploidy, enhanced green fluorescent protein (EGFP)-tagged PTTG (PTTG-EGFP) was expressed in human H1299 cancer cells (with undetectable endogenous PTTG expression) and mitosis of individual live cells observed. Untransfected cells and cells expressing EGFP alone exhibited appropriate mitosis. PTTG-EGFP markedly prolonged prophase and metaphase, indicating that PTTG blocks progression of mitosis to anaphase. In cells that underwent apparently normal mitosis (35 of 65 cells), PTTG-EGFP was degraded about 1 min before anaphase onset. Cells that failed to degrade PTTG-EGFP exhibited asymmetrical cytokinesis without chromosome segregation (18 of 65 cells) or chromosome decondensation without cytokinesis (9 of 65 cells), resulting in appearance of a macronucleus. Fifty-one of 55 cells expressing a nondegradable mutant PTTG exhibited asymmetrical cytokinesis without chromosome segregation, and some (4 of 55) decondensed chromosomes, both resulting in macronuclear formation. During this abnormal cytokinesis, all chromosomes and spindles and both centrosomes moved to one daughter cell, suggesting potential chaos in the subsequent mitosis. In conclusion, failure of PTTG degradation or enhanced PTTG accumulation, as a consequence of overexpression, inhibits mitosis progression and chromosome segregation but does not directly affect cytokinesis, resulting in aneuploidy. These results demonstrate that PTTG induces aneuploidy in single, live, human cancer cells.

[1]  Kim Nasmyth,et al.  Segregating Sister Genomes: The Molecular Biology of Chromosome Separation , 2002, Science.

[2]  J. Peters,et al.  Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1 , 2002, The Journal of cell biology.

[3]  S. Melmed,et al.  Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. , 2001, Molecular endocrinology.

[4]  M. Glotzer,et al.  Animal cell cytokinesis. , 2001, Annual review of cell and developmental biology.

[5]  J. Peters,et al.  Cohesin Cleavage by Separase Required for Anaphase and Cytokinesis in Human Cells , 2001, Science.

[6]  S. Melmed,et al.  Oncogene Activation in Pituitary Tumors , 2001, Brain pathology.

[7]  R. DePinho,et al.  Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse. , 2001, Seminars in cancer biology.

[8]  Michael R. Speicher,et al.  Securin Is Required for Chromosomal Stability in Human Cells , 2001, Cell.

[9]  H. Clevers,et al.  Mutations in the APC tumour suppressor gene cause chromosomal instability , 2001, Nature Cell Biology.

[10]  L. Pei.  Identification of c-myc as a Down-stream Target for Pituitary Tumor-transforming Gene* , 2001, The Journal of Biological Chemistry.

[11]  F. Ishikawa,et al.  Human Chromatid Cohesin Component hRad21 Is Phosphorylated in M Phase and Associated with Metaphase Centromeres* , 2001, The Journal of Biological Chemistry.

[12]  M. Brandeis,et al.  Securin degradation is mediated by fzy and fzr, and is required for complete chromatid separation but not for cytokinesis , 2001, The EMBO journal.

[13]  J. Shah,et al.  Waiting for Anaphase Mad2 and the Spindle Assembly Checkpoint , 2000, Cell.

[14]  Jiandong Chen,et al.  Pituitary Tumor Transforming Gene Causes Aneuploidy and p53-dependent and p53-independent Apoptosis* , 2000, The Journal of Biological Chemistry.

[15]  S. Melmed,et al.  Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging. , 2000, Molecular endocrinology.

[16]  J. Tischfield,et al.  Chromosome instability contributes to loss of heterozygosity in mice lacking p53. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Duesberg,et al.  Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Melmed,et al.  Expression of pituitary-tumour transforming gene in colorectal tumours , 2000, The Lancet.

[19]  S. Melmed,et al.  Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis , 1999, Nature Medicine.

[20]  S. Reed,et al.  Deregulated cyclin E induces chromosome instability , 1999, Nature.

[21]  M. Kirschner,et al.  Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. , 1999, Science.

[22]  E. Prochownik,et al.  C-myc overexpression and p53 loss cooperate to promote genomic instability , 1999, Oncogene.

[23]  A. Valentini,et al.  Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). , 1999, Molecular endocrinology.

[24]  J. R. Daum,et al.  Mammalian p55CDC Mediates Association of the Spindle Checkpoint Protein Mad2 with the Cyclosome/Anaphase-promoting Complex, and is Involved in Regulating Anaphase Onset and Late Mitotic Events , 1998, The Journal of cell biology.

[25]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[26]  S. Melmed,et al.  Isolation and characterization of a pituitary tumor-transforming gene (PTTG). , 1997, Molecular endocrinology.

[27]  G. Gorbsky.  Cell cycle checkpoints: arresting progress in mitosis. , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[28]  S. Hilsenbeck,et al.  Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53 , 1997, Molecular and cellular biology.

[29]  G. Gorbsky,et al.  Microinjection of mitotic cells with the 3F3/2 anti-phosphoepitope antibody delays the onset of anaphase , 1995, The Journal of cell biology.

[30]  W. Ricketts,et al.  Differential expression of a phosphoepitope at the kinetochores of moving chromosomes , 1993, The Journal of cell biology.